EXELIXIS ($EXEL) posted quarterly earnings results on Tuesday, May 13th. The company reported earnings of $0.62 per share, beating estimates of $0.37 by $0.25. The company also reported revenue of $555,450,000, beating estimates of $508,139,040 by $47,310,960.
You can see Quiver Quantitative's $EXEL stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
EXELIXIS Insider Trading Activity
EXELIXIS insiders have traded $EXEL stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.
Here’s a breakdown of recent trading of $EXEL stock by insiders over the last 6 months:
- PATRICK J. HALEY (EVP, Commercial) has made 0 purchases and 5 sales selling 114,224 shares for an estimated $4,116,001.
- JULIE SMITH has made 0 purchases and 2 sales selling 73,808 shares for an estimated $2,804,459.
- JEFFREY HESSEKIEL (EVP & General Counsel) sold 60,000 shares for an estimated $2,200,200
- MARIA C FREIRE sold 44,114 shares for an estimated $1,541,343
- CHRISTOPHER J. SENNER (EVP and CFO) sold 29,314 shares for an estimated $1,059,407
- DANA AFTAB (CSO/EVP Disc & Trans Research) has made 0 purchases and 2 sales selling 28,495 shares for an estimated $1,050,584.
- BOB OLIVER sold 18,647 shares for an estimated $694,600
- GEORGE POSTE sold 15,874 shares for an estimated $551,462
- MARY C BECKERLE has made 0 purchases and 2 sales selling 12,210 shares for an estimated $425,878.
- SUE GAIL ECKHARDT has made 0 purchases and 2 sales selling 11,568 shares for an estimated $405,111.
- JACK L WYSZOMIERSKI sold 8,768 shares for an estimated $331,430
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
EXELIXIS Hedge Fund Activity
We have seen 316 institutional investors add shares of EXELIXIS stock to their portfolio, and 221 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO removed 2,363,390 shares (-71.3%) from their portfolio in Q1 2025, for an estimated $87,256,358
- GEODE CAPITAL MANAGEMENT, LLC added 2,259,371 shares (+43.8%) to their portfolio in Q1 2025, for an estimated $83,415,977
- FARALLON CAPITAL MANAGEMENT LLC removed 1,971,000 shares (-7.8%) from their portfolio in Q4 2024, for an estimated $65,634,299
- CAISSE DE DEPOT ET PLACEMENT DU QUEBEC added 1,907,167 shares (+330.4%) to their portfolio in Q4 2024, for an estimated $63,508,661
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 1,613,482 shares (+104.4%) to their portfolio in Q4 2024, for an estimated $53,728,950
- BELLEVUE GROUP AG removed 1,600,000 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $53,279,999
- INVESCO LTD. added 1,596,948 shares (+40.2%) to their portfolio in Q1 2025, for an estimated $58,959,320
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
EXELIXIS Analyst Ratings
Wall Street analysts have issued reports on $EXEL in the last several months. We have seen 6 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Underperform" rating on 04/17/2025
- Wells Fargo issued a "Market Outperform" rating on 04/17/2025
- JMP Securities issued a "Market Outperform" rating on 01/27/2025
- H.C. Wainwright issued a "Buy" rating on 01/10/2025
- Citigroup issued a "Buy" rating on 01/09/2025
- Guggenheim issued a "Buy" rating on 01/07/2025
- RBC Capital issued a "Outperform" rating on 12/30/2024
To track analyst ratings and price targets for EXELIXIS, check out Quiver Quantitative's $EXEL forecast page.
EXELIXIS Price Targets
Multiple analysts have issued price targets for $EXEL recently. We have seen 4 analysts offer price targets for $EXEL in the last 6 months, with a median target of $40.5.
Here are some recent targets:
- An analyst from RBC Capital set a target price of $40.0 on 03/13/2025
- Silvan Tuerkcan from JMP Securities set a target price of $41.0 on 01/27/2025
- Robert Burns from H.C. Wainwright set a target price of $40.0 on 01/10/2025
- Michael Schmidt from Guggenheim set a target price of $42.0 on 01/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
